WAYNE, Pa.--(BUSINESS WIRE)--May 15, 2017--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care, urology and surgery, will showcase its
complex PCI product portfolio recently acquired from the purchase of
Vascular Solutions and the new Arrow® AC3 Optimus™
Intra-Aortic Balloon Pump (IABP) at the EuroPCR being held in Paris,
France on May 16-19, 2017.
With the recent acquisition of Vascular Solutions, Teleflex now offers a
full line of products that give interventional cardiologists the tools
they need to handle routine and complex cases, resulting in improved
outcomes for patients. Cardiologists worldwide rely on the quality and
proven clinical effectiveness of products, such as the GuideLiner®
Catheter Platform, TrapLiner™ Catheter, Turnpike® Catheter,
Twin-Pass® Torque Dual Access Catheter, and R350™ Guidewire.
Teleflex will also introduce the new Arrow® AC3 Optimus IABP.
This device helps a weakened heart pump blood and can deliver IABP
therapy to a broad range of patients, even those not previously
considered candidates for IABP therapy. Clinicians may use the pump on
patients with the most severe arrhythmias or with heart rates as high as
200 beats per minute.1, 2
The Arrow® AC3 Optimus™ IABP has a third-generation AutoPilot®
Mode, which uses proprietary algorithms to address key clinical
challenges and to simplify the delivery of IABP therapy.3 In
AutoPilot® Mode, the Arrow® AC3 Optimus™ IABP automatically
adjusts timing and triggering parameters, freeing clinicians to focus on
the patient rather than the pump. In addition, the Arrow® AC3
Optimus™ IABP includes several exclusive algorithms, such as WAVE®
Inflation Timing, Deflation Timing Management, and Best Signal Analysis,
which optimize key functions of the IABP to deliver therapy to the most
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®
and Weck® – trusted brands united by a common sense of
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, AC3 Optimus, AutoPilot, Deknatel,
Hudson RCI, LMA, Pilling, R350, Rusch, WAVE, and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries.
© 2017 Teleflex Incorporated. All
Schreuder J, Castiglioni A, Donelli A, et al. Automatic intraaortic
balloon pump timing using an intra beat dicrotic notch prediction
algorithm. Ann Thorac Surg. 2005;79(3):1017-1022. Study
sponsored by Teleflex.
Donelli A, Jansen JRC, Hoeksel B, et al. Performance of a real-time
dicrotic notch detection and prediction algorithm in arrhythmic human
aortic pressure signals. J Clin Monit. 2002;17(3-4):181-185.
Study sponsored by Teleflex.
Torracca, L. Overcoming electro-surgical inference in IABP therapy
with the combined use of AutoPilot and FiberOptix IAB sensor signal.
2007. (Case report, data on file). Study sponsored by Teleflex.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170515006618/en/
Source: Teleflex Incorporated
Treasurer and Vice
President, Investor Relations
Senior Director Marketing Communications